FDA Inspection 1264026 — Miracles In Sight

Miracles In Sight — FEI 3001237888

The FDA completed an inspection of Miracles In Sight on Mar 10, 2025 in Winston Salem, NC. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Mar 10, 2025
Fiscal Year
2025
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Winston Salem, NC (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.